Stocks In News - USFDA
- Glenmark Pharmaceuticals Inc, USA has been granted final approval by the United States Food & Drug Administration (USFDA) for Frovatriptan Succinate tablets, 2.5 mg.
- Frovatriptan Succinate is therapeutic equivalent to listed drug product, Frova tablets of Endo Pharmaceuticals Inc.
No comments:
Post a Comment